I am a medical oncologist who cares for people who have been admitted to Memorial Hospital to be treated for leukemia. I am also a member of MSK’s Cellular Therapeutics Center. We are working to develop the next generation of a promising type of immunotherapy called CAR T cell therapy.
Read more Read less
For as long as I can remember, I have been fascinated by the workings of cells and the immune system. These two interests converged on oncology, allowing me to focus on not only the underlying disease, but on ways to target and eradicate it through the use of immunotherapy.
When patients are in the hospital, they are often concerned about getting the most appropriate therapy for their unique disease. I try to alleviate these concerns by involving my patients in the treatment planning process and explaining the reasoning behind each approach.
After I meet with patients and their families, it’s my goal that they feel hopeful that we will help them feel better. This can mean treating their disease to cure it, and also alleviating symptoms to improve their quality of life.
- Clinical Expertise: Adult Acute and Chronic Leukemias; Adoptive Cellular Therapy
- Awards and Honors: Mortimer J. Lacher Fellowship in Hematological Oncology, Memorial Sloan Kettering (2015); Young Investigator Award, Conquer Cancer Foundation of ASCO (2017); K12 Paul Calabresi Career Development Award for Clinical Oncology, Memorial Sloan Kettering (2017)
- Languages Spoken: English
- Education: MD, University of Miami Miller School of Medicine
- Residencies: Internal Medicine - NewYork-Presbyterian Hospital/Weill Cornell Medical Center
- Fellowships: Medical Oncology - Memorial Sloan Kettering Cancer Center
- Board Certifications: Internal Medicine; Medical Oncology
Rafiq S, Purdon TJ, Daniyan AF, Koneru M, Dao T, Liu C, Scheinberg DA, Brentjens RJ.Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen. Leukemia. 2017 Aug;31(8):1788-1797. doi: 10.1038/leu.2016.373. Epub 2016 Dec 7.
Read more Read less
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more